PAREXEL offers an International Network of hospital-based Clinical Pharmacology Units that work together to provide extensive coverage and broad capabilities for single- or multi-site studies. With over 550 dedicated beds worldwide, and more than 500 validated assay methods for the analysis of over 450 drugs (together with a dedicated laboratory partner), our Network is uniquely able to provide rapid, cost-effective, and high-quality design, conduct, and management of Phase I and IIa clinical studies.
The PAREXEL Clinical Pharmacology International Network encompasses six research Units in Baltimore and Los Angeles, United States; Berlin, Germany; Bloemfontein and George, South Africa; and London, United Kingdom, along with the bioanalytical laboratory in Bloemfontein, South Africa. The mix of northern and southern hemisphere locations provides seasonal benefits for year-round studies, as well as varied volunteer populations.
Other benefits include:
- Parallel drug development in multiple Units, from First in Man to Proof of Concept
- Ability to meet worldwide regulatory requirements
- All Units are equipped with ClinBase™, an electronic data capture and information management system that is fully validated and 21CFR part 11-compliant
- Research Units based at university medical centers extend access to a broad range of specialists and scientific expertise
- Comprehensive services can be quickly and easily mobilized – and are tightly coordinated and managed – so that global resources are available regardless of where a study is based
- Reduced time-to-market for promising new compounds
Baltimore, USA
Los Angeles, USA
Berlin, Germany
Bloemfontein, South Africa
George, South Africa
London, UK